GEN talked with several contract development and manufacturing organizations (CDMOs) and/or contract research organizations (CROs) about new ways they are addressing AAV manufacturing challenges.

The Milan Cell and Gene Center of Excellence at AGC Biologics will produce LVV material for Treg cell therapy candidates.

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Hualong ...

May 2025 - eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, has entered into a strategic partnership with KU Leuven, one of Europe’s leading academic ...

There are still no vaccines for most neglected tropical diseases. Read more at straitstimes.com. Read more at ...

Q1 2025 Earnings Call Transcript May 15, 2025 Taysha Gene Therapies, Inc. reports earnings inline with expectations. Reported ...

Manufacturing of the tecarfarin drug product candidate is currently underway. "We are pleased with the important progress we have made with the supply chain and cGMP manufacturing process for ...

Ireland’s largest gathering of manufacturing and supply chain professionals takes place on May 28th and 29th next at RDS Simmonscourt, Dublin. The 12th edition of the National Manufacturing ...

Greg Vetter, entrepreneur, founder of Alta Fresh Foods, and author of Undressed.

The company has received FDA's Regenerative Medicine Advanced Therapy designation for LYL314, which is manufactured at its LyFE Manufacturing ... are pleased with the progress we are making ...